KBRA Assigns Preliminary Ratings to New Residential Mortgage Trust 2022-NQM3 (NRMLT 2022-NQM3)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to six classes of mortgage-backed notes from New Residential…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to six classes of mortgage-backed notes from New Residential…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to five classes of mortgage pass-through notes from GCAT…
MulticoreWare Inc. introduces HuBe.ai – The first of its kind Human Behavior Intelligence (HBI) Cloud…
New York City charter schools adopt PowerSchool Unified Classroom® Schoology Learning and PowerSchool Unified Classroom®…
Lincoln Prairie by Del Webb will offer single-family ranch homes and resort-style amenities for 55+…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its auto loan ABS indices for March 2022. March remittance reports…
● Fireside Chat with B. Riley Research Scheduled for Thursday, April 28th, at 10:00 AM…
Former Fieldpoint Private VP Joins the Firm as Vice President and Senior Portfolio Consultant NEW…
Anne Fitzpatrick Donahue assumes role in Greater New York NEW YORK–(BUSINESS WIRE)–Northern Trust has appointed…
Trusted Capital Markets Partner Bolsters Client-Facing Teams with New Hires and Promotions SAN DIEGO–(BUSINESS WIRE)–Mortgage…
Part 1: A New Way to Kill Tumors–IO102-IO103 Phase 3 Trial in Combination with Anti-PD-1…
LAKE FOREST, Ill., April 22, 2022 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…
HOUSTON, April 22, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
Additional data collection and analysis reconfirms confidence in New Drug Application for Treosulfan NDA resubmission…
JERSEY CITY, N.J., April 22, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (Nasdaq: SCYX) today announced…
Elects Mr. Quinton Oswald and Dr. Susan Orr, deeply experienced Ophthalmology Executives, at a General Meeting of Shareholders MELBOURNE, Australia,…
SINGAPORE and ISELIN, N.J., April 22, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK),…
Data reinforce findings from previous analyses demonstrating oral ibrexafungerp’s potential to combat difficult-to-treat and refractory…
Philadelphia, PA, April 22, 2022 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or…
REDWOOD CITY, Calif., April 22, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…